These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

386 related articles for article (PubMed ID: 25771849)

  • 41. Influence of methylphenidate on spatial attention asymmetry in adolescents with attention deficit hyperactivity disorder (ADHD): preliminary findings.
    Silk TJ; Newman DP; Eramudugolla R; Vance A; Bellgrove MA
    Neuropsychologia; 2014 Apr; 56():178-83. PubMed ID: 24486422
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Efficacy and tolerability of OROS methylphenidate in Korean children with attention-deficit/hyperactivity disorder.
    Lee SI; Hong SD; Kim SY; Kim EJ; Kim JH; Kim JH; Park MK; Park S; Park JH; Oh EY; Lim TS; Cheong S; Cho IH; Choi JW
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Jan; 31(1):210-6. PubMed ID: 17046131
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Acute neuropsychological effects of methylphenidate in stimulant drug-naïve boys with ADHD II--broader executive and non-executive domains.
    Rhodes SM; Coghill DR; Matthews K
    J Child Psychol Psychiatry; 2006 Nov; 47(11):1184-94. PubMed ID: 17076758
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Comparative pharmacodynamics and plasma concentrations of d-threo-methylphenidate hydrochloride after single doses of d-threo-methylphenidate hydrochloride and d,l-threo-methylphenidate hydrochloride in a double-blind, placebo-controlled, crossover laboratory school study in children with attention-deficit/hyperactivity disorder.
    Quinn D; Wigal S; Swanson J; Hirsch S; Ottolini Y; Dariani M; Roffman M; Zeldis J; Cooper T
    J Am Acad Child Adolesc Psychiatry; 2004 Nov; 43(11):1422-9. PubMed ID: 15502602
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Association between dopamine transporter (DAT1) genotype, left-sided inattention, and an enhanced response to methylphenidate in attention-deficit hyperactivity disorder.
    Bellgrove MA; Hawi Z; Kirley A; Fitzgerald M; Gill M; Robertson IH
    Neuropsychopharmacology; 2005 Dec; 30(12):2290-7. PubMed ID: 16123773
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Methylphenidate HCL for the treatment of ADHD in children and adolescents.
    Childress AC
    Expert Opin Pharmacother; 2016 Jun; 17(8):1171-8. PubMed ID: 27114115
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Electrophysiological investigation of the effectiveness of methylphenidate in children with and without ADHD.
    Seifert J; Scheuerpflug P; Zillessen KE; Fallgatter A; Warnke A
    J Neural Transm (Vienna); 2003 Jul; 110(7):821-9. PubMed ID: 12811642
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Methylphenidate does not improve interference control during a working memory task in young patients with attention-deficit hyperactivity disorder.
    Prehn-Kristensen A; Krauel K; Hinrichs H; Fischer J; Malecki U; Schuetze H; Wolff S; Jansen O; Duezel E; Baving L
    Brain Res; 2011 May; 1388():56-68. PubMed ID: 21385569
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The relationship between symptomatic and functional changes of Korean children and adolescents with attention-deficit/hyperactivity disorder treated with osmotic-controlled release oral delivery system-methylphenidate.
    Kim E; Cheon KA; Joung YS; Kim JY; Song DH
    Clin Neuropharmacol; 2015; 38(1):30-5. PubMed ID: 25580917
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Transdermal methylphenidate, behavioral, and combined treatment for children with ADHD.
    Pelham WE; Burrows-Maclean L; Gnagy EM; Fabiano GA; Coles EK; Tresco KE; Chacko A; Wymbs BT; Wienke AL; Walker KS; Hoffman MT
    Exp Clin Psychopharmacol; 2005 May; 13(2):111-26. PubMed ID: 15943544
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Methylphenidate improves response inhibition but not reflection-impulsivity in children with attention deficit hyperactivity disorder (ADHD).
    DeVito EE; Blackwell AD; Clark L; Kent L; Dezsery AM; Turner DC; Aitken MR; Sahakian BJ
    Psychopharmacology (Berl); 2009 Jan; 202(1-3):531-9. PubMed ID: 18818905
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Relative benefits of stimulant therapy with OROS methylphenidate versus mixed amphetamine salts extended release in improving the driving performance of adolescent drivers with attention-deficit/hyperactivity disorder.
    Cox DJ; Merkel RL; Moore M; Thorndike F; Muller C; Kovatchev B
    Pediatrics; 2006 Sep; 118(3):e704-10. PubMed ID: 16950962
    [TBL] [Abstract][Full Text] [Related]  

  • 53. An open-label, randomized, active-controlled equivalent trial of osmotic release oral system methylphenidate in children with attention-deficit/hyperactivity disorder in Taiwan.
    Gau SS; Shen HY; Soong WT; Gau CS
    J Child Adolesc Psychopharmacol; 2006 Aug; 16(4):441-55. PubMed ID: 16958569
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Baseline severity of parent-perceived inattentiveness is predictive of the difference between subjective and objective methylphenidate responses in children with attention-deficit/hyperactivity disorder.
    Park S; Kim BN; Cho SC; Kim JW; Shin MS; Yoo HJ; Han DH; Cheong JH
    J Child Adolesc Psychopharmacol; 2013 Aug; 23(6):410-4. PubMed ID: 23952188
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Using the test of variables of attention to determine the effectiveness of modafinil in children with attention-deficit hyperactivity disorder (ADHD): a prospective methylphenidate-controlled trial.
    Goez HR; Scott O; Nevo N; Bennett-Back O; Zelnik N
    J Child Neurol; 2012 Dec; 27(12):1547-52. PubMed ID: 22447850
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Clinical and cognitive response to extended-release methylphenidate (Medikinet) in attention deficit/hyperactivity disorder: efficacy evaluation.
    Fernández-Jaén A; Fernández-Mayoralas DM; Pardos A; Calleja-Pérez B; Muñoz Jareño N
    Adv Ther; 2009 Dec; 26(12):1097-110. PubMed ID: 20082241
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The Visuo-Motor Attention Test in Boys with Attention Deficit Hyperactivity Disorder (ADHD): Methylphenidate-Placebo Randomized Controlled Trial.
    Hadar Y; Hocherman S; Lamm O; Tirosh E
    Child Psychiatry Hum Dev; 2021 Feb; 52(1):96-103. PubMed ID: 32342235
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Pay attention to impulsivity: modelling low attentive and high impulsive subtypes of adult ADHD in the 5-choice continuous performance task (5C-CPT) in female rats.
    Tomlinson A; Grayson B; Marsh S; Harte MK; Barnes SA; Marshall KM; Neill JC
    Eur Neuropsychopharmacol; 2014 Aug; 24(8):1371-80. PubMed ID: 24882551
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Attention-deficit/hyperactivity disorder with obstructive sleep apnea: a treatment outcome study.
    Huang YS; Guilleminault C; Li HY; Yang CM; Wu YY; Chen NH
    Sleep Med; 2007 Jan; 8(1):18-30. PubMed ID: 17157069
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Long-term neurocognitive effects of methylphenidate in patients with attention deficit hyperactivity disorder, even at drug-free status.
    Huang YS; Wang LJ; Chen CK
    BMC Psychiatry; 2012 Nov; 12():194. PubMed ID: 23140464
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.